The company's expertise in translating scientific innovations into commercial products is expected to accelerate the journey ...

The vaccine, jointly developed by the National Institute of Virology-Pune and Hyderabad-based Bharat Biotech International Limited (BBIL) in collaboration with the Indian Council of Medical ...

These probiotics have shown great potential in addressing metabolic diseases, improving gut health, and promoting healthy ...

The Institute of Advanced Study in Science and Technology (IASST) collaborates with Bharat Biotech to develop health products ...

IASST, Guwahati, has partnered with Bharat Biotech to develop innovative health products from probiotics derived from ...

Guwahati, an autonomous institution of Department of Science and Technology (DST) signed a crucial R&D collaboration and ...

According to sources, in the minutes of the meeting of Subject Expert Committee (SEC) held on March 30, 2024, the firm presented Phase I clinical trial report with 28 days safety results along ...

HYDERABAD: Bharat Biotech International Limited (BBIL) on Tuesday announced the rollout of HILLCHOL (BBV131), a novel ...

Hyderabad, Feb. 24 (PTI): COVID-19 vaccine Covaxin maker Bharat Biotech International Limited is in the process of bringing out a vaccine against tuberculosis and soon the firm will sign a MoU ...

While Bharat Biotech, a global leader in vaccine and health solutions, will conduct pre-clinical and clinical trials, the ...

As part of the Phase II/III trial, the two-dose Covaxin was administered with 28 days apart. Bharat Biotech, which completed the Phase 2/3 trials of COVID-19 vaccine Covaxin for use in children ...

Chairman and Managing Director of Bharat Biotech International Ltd. The state has a robust transportation network and a well-established healthcare system. Kerala had set an example for other ...